NASDAQ:MNKD

Mannkind Stock Insider Trading

Healthcare > Biotechnology

Buy MNKD

*Your capital is at risk

$3.36

-0.0700 (-2.04%)

At Close: Jun 03, 2026

MannKind Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -12.18. In total, the insiders bought 8.03M and sold 1.36M MNKD shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	-12.18
● Buy	8.03M shares
● Sell	1.36M shares
62% Buy Activity Moderate Negative Correlation
Buy Signal Low Confidence Mar 23, 2026 Analysis Breakdown: Weakened by a contradictory negative Insider Power Score. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
Dec 17, 2025 Buy	Common Stock, $0.01 Par Value M-Exempt	Castagna Michael Chief Executive Officer	CEO / President	65 804 Value: $299.4K
Dec 17, 2025 Sell	Common Stock, $0.01 Par Value S-Sale	Castagna Michael Chief Executive Officer	CEO / President	65 804 Value: $395.5K
Dec 17, 2025 Buy	Employee Stock Option (Right to Buy) M-Exempt	Castagna Michael Chief Executive Officer	CEO / President	50 000 Value: $227.5K
Dec 16, 2025 Buy	Common Stock, $0.01 Par Value M-Exempt	Castagna Michael Chief Executive Officer	CEO / President	21 310 Value: $97.0K
Dec 16, 2025 Sell	Common Stock, $0.01 Par Value S-Sale	Castagna Michael Chief Executive Officer	CEO / President	21 310 Value: $127.9K
Dec 16, 2025 Buy	Employee Stock Option (Right to Buy) M-Exempt	Castagna Michael Chief Executive Officer	CEO / President	21 310 Value: $97.0K
Dec 12, 2025 Buy	Common Stock, $0.01 Par Value M-Exempt	Castagna Michael Chief Executive Officer	CEO / President	20 806 Value: $94.7K
Dec 12, 2025 Buy	Employee Stock Option (Right to Buy) M-Exempt	Castagna Michael Chief Executive Officer	CEO / President	12 886 Value: $58.6K
Dec 12, 2025 Buy	Employee Stock Option (Right to Buy) M-Exempt	Castagna Michael Chief Executive Officer	CEO / President	7 920 Value: $36.0K
Dec 02, 2025 Buy	Employee Stock Option (Right to Buy) M-Exempt	Thomson David EVP Genl Counsel & Secretary	Officer	20 000 Value: $91.0K
Dec 02, 2025 Buy	Employee Stock Option (Right to Buy) M-Exempt	Thomson David EVP Genl Counsel & Secretary	Officer	87 780 Value: $403.8K
Dec 02, 2025 Sell	Common Stock, $0.01 Par Value S-Sale	Thomson David EVP Genl Counsel & Secretary	Officer	147 780 Value: $823.1K
Dec 02, 2025 Buy	Common Stock, $0.01 Par Value M-Exempt	Thomson David EVP Genl Counsel & Secretary	Officer	60 000 Value: $273.0K
Dec 02, 2025 Buy	Common Stock, $0.01 Par Value M-Exempt	Thomson David EVP Genl Counsel & Secretary	Officer	87 780 Value: $403.8K
Dec 02, 2025 Buy	Employee Stock Option (Right to Buy) M-Exempt	Castagna Michael Chief Executive Officer	CEO / President	65 840 Value: $299.6K
Dec 02, 2025 Buy	Employee Stock Option (Right to Buy) M-Exempt	Castagna Michael Chief Executive Officer	CEO / President	42 080 Value: $191.5K
Dec 02, 2025 Sell	Common Stock, $0.01 Par Value S-Sale	Castagna Michael Chief Executive Officer	CEO / President	107 920 Value: $601.1K
Dec 02, 2025 Buy	Common Stock, $0.01 Par Value M-Exempt	Castagna Michael Chief Executive Officer	CEO / President	107 920 Value: $491.0K
Nov 14, 2025 Sell	Common Stock, $0.01 Par Value S-Sale	Singh Sanjay R EVP Technical Operations	Officer	18 777 Value: $94.4K
Nov 11, 2025 Buy	Common Stock, $0.01 Par Value A-Award	Ahuja Ajay Chief Medical Officer	Officer	318 200 Value: $1.67M
Oct 31, 2025 Sell	Common Stock, $0.01 Par Value F-InKind	Singh Sanjay R EVP Technical Operations	Officer	17 071 Value: $95.4K
Sep 29, 2025 Buy	Common Stock J-Other	Ahuja Ajay Insider	Other	0 Value: $0
Sep 29, 2025 Buy	Common Stock J-Other	Ahuja Ajay Insider	Other	0 Value: $0
Sep 16, 2025 Sell	Common Stock, $0.01 Par Value S-Sale	Tross Stuart A Chief People & Workpl Officer	Officer	47 000 Value: $251.0K
Sep 16, 2025 Sell	Common Stock, $0.01 Par Value S-Sale	Tross Stuart A Chief People & Workpl Officer	Officer	47 000 Value: $251.0K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT MANNKIND CORPORATION

MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocrinologists, and other healthcare providers for the treatment of hypothyroidism. The company has a licens...

Read Full Profile Here